Trius Therapeutics triusrx.com


Public list: Smart Money VCs (6328) Pharma Startups (4732)

Trius Therapeutics is discovering and developing antibacterial drugs for the treatment of life-threatening infections. The company's lead product candidate, TR-701 is a oral and IV oxazolidinone antibiotic with potent activity against Gram positive bacterial pathogens. Trius' pipeline includes three additional structure-based drug design programs directed against antibacterial targets.

Trius Therapeutics is discovering and developing antibacterial drugs for the treatment of life-threatening infections. The company's lead product candidate, TR-701 is a oral and IV oxazolidinone antibiotic with potent activity against Gram positive b...Show all

Company (Acquired)

Phone: 858-452-0370

Fax:

6310 Nancy Ridge Drive
Suite 101
San Diego, 92121
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Trius Therapeutics $129.5M Sep 12, 2013
See all 20 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Trius Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Kleiner Perkins Caufield & ByersVenture CapitalMenlo Park, California, United StatesSeries B
InterWest PartnersVenture CapitalMenlo Park, California, United StatesSeries B, Series A
Prism VentureWorksVenture CapitalNeedham, Massachusetts, United StatesSeries B, Series A
FinTech Global CapitalVenture CapitalJapanSeries B
Defense Threat Reduction AgencyGovernmentVirginia, United StatesGrant
See all 7 investors

Competitors

Company Status Description Investors
See all 20 competitors